Comerica Bank Myriad Genetics Inc Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Myriad Genetics Inc stock. As of the latest transaction made, Comerica Bank holds 35,272 shares of MYGN stock, worth $539,661. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,272

Previous 71,334 50.55%

Holding current value

$539,661

Previous $1.74 Million 44.67%

% of portfolio

0.0%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.97 - $28.6 $864,406 - $1.03 Million	-36,062 Reduced 50.55%	35,272 $965,000
Q2 2024 Aug 15, 2024	SELL	$17.98 - $25.47 $155,509 - $220,290	-8,649 Reduced 10.81%	71,334 $1.74 Million
Q1 2024 May 15, 2024	SELL	$17.59 - $23.59 $50,219 - $67,349	-2,855 Reduced 3.45%	79,983 $1.71 Million
Q4 2023 Feb 14, 2024	BUY	$13.91 - $21.32 $29,809 - $45,688	2,143 Added 2.66%	82,838 $1.59 Million
Q3 2023 Nov 21, 2023	SELL	$15.99 - $23.22 $258,126 - $374,840	-16,143 Reduced 16.67%	80,695 $1.29 Million
Q2 2023 Aug 22, 2023	BUY	$17.56 - $23.76 $150,471 - $203,599	8,569 Added 9.71%	96,838 $3,000
Q4 2022 Jan 26, 2023	SELL	$14.51 - $20.99 $196,102 - $283,679	-13,515 Reduced 13.28%	88,269 $0
Q3 2022 Oct 28, 2022	SELL	$18.21 - $27.88 $120,641 - $184,705	-6,625 Reduced 6.11%	101,784 $1.92 Million
Q2 2022 Aug 02, 2022	BUY	$16.45 - $25.88 $42,605 - $67,029	2,590 Added 2.45%	108,409 $2.47 Million
Q1 2022 Apr 27, 2022	SELL	$22.67 - $28.01 $25,957 - $32,071	-1,145 Reduced 1.07%	105,819 $2.67 Million
Q4 2021 Feb 18, 2022	SELL	$24.13 - $32.63 $92,514 - $125,103	-3,834 Reduced 3.46%	106,964 $2.95 Million
Q3 2021 Nov 22, 2021	SELL	$29.97 - $36.66 $50,978 - $62,358	-1,701 Reduced 1.51%	110,798 $3.58 Million
Q2 2021 Aug 26, 2021	SELL	$25.39 - $32.61 $94,450 - $121,309	-3,720 Reduced 3.2%	112,499 $3.44 Million
Q1 2021 Apr 28, 2021	SELL	$19.92 - $31.6 $59,799 - $94,863	-3,002 Reduced 2.52%	116,219 $3.54 Million
Q4 2020 Jan 28, 2021	BUY	$12.16 - $19.77 $6,773 - $11,011	557 Added 0.47%	119,221 $2.36 Million
Q3 2020 Oct 30, 2020	SELL	$11.25 - $14.75 $2,531 - $3,318	-225 Reduced 0.19%	118,664 $1.55 Million
Q2 2020 Jul 31, 2020	BUY	$10.69 - $16.49 $65,732 - $101,397	6,149 Added 5.45%	118,889 $1.35 Million
Q1 2020 May 01, 2020	BUY	$9.78 - $29.53 $24,890 - $75,153	2,545 Added 2.31%	112,740 $1.61 Million
Q4 2019 Feb 07, 2020	BUY	$20.93 - $35.1 $10,778 - $18,076	515 Added 0.47%	110,195 $3 Million
Q3 2019 Oct 31, 2019	BUY	$22.08 - $47.08 $10,223 - $21,798	463 Added 0.42%	109,680 $3.14 Million
Q2 2019 Aug 02, 2019	SELL	$22.67 - $35.0 $82,790 - $127,820	-3,652 Reduced 3.24%	109,217 $0
Q1 2019 May 02, 2019	SELL	$26.93 - $34.7 $153,070 - $197,234	-5,684 Reduced 4.79%	112,869 $0
Q4 2018 Feb 06, 2019	BUY	$27.23 - $45.56 $152,869 - $255,773	5,614 Added 4.97%	118,553 $3.27 Million
Q3 2018 Nov 01, 2018	SELL	$37.57 - $50.34 $201,976 - $270,627	-5,376 Reduced 4.54%	112,939 $4.9 Million
Q2 2018 Aug 01, 2018	SELL	$27.75 - $40.17 $81,279 - $117,657	-2,929 Reduced 2.42%	118,315 $5.07 Million
Q1 2018 May 01, 2018	BUY	$28.83 - $41.01 $62,070 - $88,294	2,153 Added 1.81%	121,244 $3.52 Million
Q4 2017 Feb 02, 2018	SELL	$28.45 - $37.14 $29,189 - $38,105	-1,026 Reduced 0.85%	119,091 $4.81 Million
Q3 2017 Nov 06, 2017	BUY	$24.01 - $36.2 $2.88 Million - $4.35 Million	120,117	120,117 $4.14 Million

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.9M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.23B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account